Pylarify (piflufolastat f 18).

Ended Awarded Last action

Contract number
36C26025F0258
Awardee
Awarding agency
Obligated
$415,003

Award facts

Contract value 100% obligated
$415,002.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
North Billerica, Billerica, MA 01862, USA

Award details come from SAM.gov/FPDS.

About this award

This is a federal contract award to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc. The contract, valued at $415,002.80, is a firm fixed-price delivery order for the supply of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer.

The contract is issued by the Department of Veterans Affairs (VA) through Veterans Integrated Service Network 20 (VISN 20). It is not a set-aside contract. Lantheus Holdings, Inc., the parent company of Progenics Pharmaceuticals, holds several significant Indefinite Delivery Vehicles (IDVs) with the VA and Defense Health Agency (DHA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which allow for the efficient procurement of radiopharmaceuticals and diagnostic imaging agents to support federal healthcare programs, including those at VA medical centers and military treatment facilities.

Quick answers

Who was awarded contract 36C26025F0258?

36C26025F0258 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on July 1, 2025.

How much is contract 36C26025F0258 worth?

The government has obligated $415,003 on 36C26025F0258.

Is contract 36C26025F0258 an order under another contract?

Yes. 36C26025F0258 is a delivery order under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26025F0258 competed?

The extent of competition for 36C26025F0258 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award